pacira-bioscience-logO.png
New Retrospective Analysis Shows EXPAREL Associated with Significantly Less Opioid Use Following Third Molar Extraction
June 26, 2019 07:30 ET | Pacira BioSciences
PARSIPPANY, N.J., June 26, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced results of a new analysis of patients undergoing elective third molar (“wisdom teeth”)...
Pacira_logo[1].JPG
EXPAREL Achieves Statistically Significant Reductions in Opioid Consumption and Pain Scores in Cesarean Section Patients
January 16, 2019 07:30 ET | Pacira Pharmaceuticals, Inc.
PARSIPPANY, N.J., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that its Phase 4 study of EXPAREL® (bupivacaine liposome injectable suspension) in...
Pacira_logo[1].JPG
Aetna Offers Expanded Coverage for EXPAREL® in Select Ambulatory Surgical Centers 
October 30, 2018 07:30 ET | Pacira Pharmaceuticals, Inc.
Aetna will reimburse for the use of EXPAREL in ambulatory surgical centers in Florida and New Jersey as part of a pilot program       PARSIPPANY, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Aetna has...
pacira-bioscience-logO.png
New Research Shows Vast Majority of Oral Surgery Patients Would Choose Non-opioid Medication to Treat Postsurgical Pain if Given the Option
May 03, 2017 11:00 ET | Pacira Pharmaceuticals, Inc
PARSIPPANY, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- According to a new national survey of over 1,500 oral surgery patients or their parents, more than seven in 10 respondents indicated they would opt...
Plastic Surgeon in M
Plastic Surgeon in Manhattan Reveals Customized Approach to Mommy Makeovers
March 18, 2014 09:01 ET | Stafford R. Broumand, MD
NEW YORK, NY--(Marketwired - Mar 18, 2014) - "The process of restoring one's body to its pre-pregnancy form can be difficult and often frustrating," says Manhattan plastic surgeon Stafford R....